The University of Chicago Header Logo

Connection

Janardan Khandekar to Humans

Back to Details
This is a "connection" page, showing publications Janardan Khandekar has written about Humans.
Janardan Khandekar
Connection Strength
0.224
Humans
  1. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am J Health Syst Pharm. 2016 Dec 01; 73(23):1956-1966.
    View in: PubMed
    Score: 0.017
  2. Value of Personalized Medicine. JAMA. 2016 Feb 09; 315(6):612-3.
    View in: PubMed
    Score: 0.016
  3. Direct observation of genomic heterogeneity through local haplotyping analysis. BMC Genomics. 2014 Jun 02; 15:418.
    View in: PubMed
    Score: 0.015
  4. APC gene testing for familial adenomatosis polyposis. JAMA. 2012 Aug 01; 308(5):514-5.
    View in: PubMed
    Score: 0.013
  5. Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol. 2012 Jan; 22(1):17-27.
    View in: PubMed
    Score: 0.012
  6. Biomarkers for the early detection of cancer: an inflammatory concept. Arch Intern Med. 2007 Sep 24; 167(17):1822-4.
    View in: PubMed
    Score: 0.009
  7. Phase 1 clinical trials: not just for safety anymore? Arch Intern Med. 2006 Jul 24; 166(14):1440-1.
    View in: PubMed
    Score: 0.009
  8. Evolving molecular-based targeted therapy for cancer: an exciting field. Compr Ther. 2005; 31(4):299-305.
    View in: PubMed
    Score: 0.008
  9. Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort. Thromb Res. 2023 09; 229:69-72.
    View in: PubMed
    Score: 0.007
  10. Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample. PLoS One. 2021; 16(10):e0258970.
    View in: PubMed
    Score: 0.006
  11. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers. Gynecol Oncol. 2021 11; 163(2):220-228.
    View in: PubMed
    Score: 0.006
  12. Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank. Am J Trop Med Hyg. 2021 Jun 15; 105(2):368-371.
    View in: PubMed
    Score: 0.006
  13. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
    View in: PubMed
    Score: 0.005
  14. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
    View in: PubMed
    Score: 0.004
  15. Recommendations on follow-up of breast cancer patients following primary therapy. Semin Surg Oncol. 1996 Sep-Oct; 12(5):346-51.
    View in: PubMed
    Score: 0.004
  16. Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit. J Cancer Surviv. 2016 Feb; 10(1):206-19.
    View in: PubMed
    Score: 0.004
  17. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar; 2(2):160-4.
    View in: PubMed
    Score: 0.004
  18. Delayed recurrences in primary fallopian tube carcinoma. South Med J. 1993 Nov; 86(11):1314-5.
    View in: PubMed
    Score: 0.004
  19. Extragonadal seminoma involving urinary bladder and arising in the prostate. Cancer. 1993 Jun 15; 71(12):3972-4.
    View in: PubMed
    Score: 0.003
  20. Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study. Breast Cancer Res Treat. 2013 Jun; 139(3):821-31.
    View in: PubMed
    Score: 0.003
  21. Implementation of EHR-based strategies to improve outpatient CAD care. Am J Manag Care. 2012 10; 18(10):603-10.
    View in: PubMed
    Score: 0.003
  22. Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative. Cancer. 2012 Oct 15; 118(20):5124-31.
    View in: PubMed
    Score: 0.003
  23. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery. J Postgrad Med. 2012 Jan-Mar; 58(1):8-13.
    View in: PubMed
    Score: 0.003
  24. Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system. Med Care. 2011 Feb; 49(2):117-25.
    View in: PubMed
    Score: 0.003
  25. Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients. Arch Dermatol. 1990 Dec; 126(12):1660.
    View in: PubMed
    Score: 0.003
  26. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Cell Cycle. 2010 Jul 01; 9(13):2663-73.
    View in: PubMed
    Score: 0.003
  27. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis. 2010 Mar; 31(3):489-95.
    View in: PubMed
    Score: 0.003
  28. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
    View in: PubMed
    Score: 0.002
  29. Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. Cancer Invest. 2007 Aug; 25(5):366-71.
    View in: PubMed
    Score: 0.002
  30. Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study. Cancer. 2006 Feb 01; 106(3):654-63.
    View in: PubMed
    Score: 0.002
  31. Recurrence in patients on adjuvant chemotherapy for breast cancer. Cancer. 1985 Dec 01; 56(11):2736.
    View in: PubMed
    Score: 0.002
  32. Residency training in the modern era: the pipe dream of less time to learn more, care better, and be more professional. Arch Intern Med. 2005 Dec 12-26; 165(22):2561-2.
    View in: PubMed
    Score: 0.002
  33. Association of nonmelanoma skin cancer with second malignancy. Cancer. 2004 Jan 01; 100(1):130-8.
    View in: PubMed
    Score: 0.002
  34. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003 Jun 25; 289(24):3243-53.
    View in: PubMed
    Score: 0.002
  35. Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983 Apr; 6(2):203-5.
    View in: PubMed
    Score: 0.002
  36. Development and evaluation of cancer chemotherapy drug information cards (DIC). J Surg Oncol. 1983 Apr; 22(4):246-8.
    View in: PubMed
    Score: 0.002
  37. Causes and evaluation of tumor-induced hypoglycemia. Arch Surg. 1982 Jul; 117(7):905-8.
    View in: PubMed
    Score: 0.002
  38. Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1982 Feb; 66(2):405-6.
    View in: PubMed
    Score: 0.002
  39. The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg. 2001 Jul; 193(1):22-8.
    View in: PubMed
    Score: 0.001
  40. Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr; 24(2):150-4.
    View in: PubMed
    Score: 0.001
  41. Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin. Cancer. 1979 Dec; 44(6):2014-6.
    View in: PubMed
    Score: 0.001
  42. A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments. Cancer. 1979 Sep; 44(3):824-30.
    View in: PubMed
    Score: 0.001
  43. A method for the quantitative analysis of human heat shock gene expression using a multiplex RT-PCR assay. Cell Stress Chaperones. 1999 Sep; 4(3):153-61.
    View in: PubMed
    Score: 0.001
  44. Carcinoma in a heterotopically auto-implanted nipple. Cancer. 1979 Jun; 43(6):2502-3.
    View in: PubMed
    Score: 0.001
  45. Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93). Am J Clin Oncol. 1998 Dec; 21(6):553-6.
    View in: PubMed
    Score: 0.001
  46. Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases. Arch Intern Med. 1978 Apr; 138(4):539-41.
    View in: PubMed
    Score: 0.001
  47. Acute erythroleukemia complicating prolonged chemotherapy for ovarian carcinoma. Arch Intern Med. 1977 Mar; 137(3):355-6.
    View in: PubMed
    Score: 0.001
  48. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):793-802.
    View in: PubMed
    Score: 0.001
  49. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Invest New Drugs. 1994; 12(4):299-301.
    View in: PubMed
    Score: 0.001
  50. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol. 1993 Nov; 11(11):2072-80.
    View in: PubMed
    Score: 0.001
  51. Achieving local control for inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1992 Aug; 175(2):141-4.
    View in: PubMed
    Score: 0.001
  52. Organophosphate poisoning. JAMA. 1971 Sep 27; 217(13):1864.
    View in: PubMed
    Score: 0.001
  53. Current status: evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study. Prog Clin Biol Res. 1990; 339:201-9.
    View in: PubMed
    Score: 0.001
  54. A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer. 1989 Dec 15; 64(12):2445-7.
    View in: PubMed
    Score: 0.001
  55. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest New Drugs. 1989 Jul; 7(2-3):255-60.
    View in: PubMed
    Score: 0.001
  56. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1987 Jun; 71(6):649-50.
    View in: PubMed
    Score: 0.001
  57. Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms. J Clin Oncol. 1987 Mar; 5(3):464-71.
    View in: PubMed
    Score: 0.001
  58. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery. 1986 Mar; 18(3):335-40.
    View in: PubMed
    Score: 0.001
  59. Thyroid hormone administration in irradiated patients. J Surg Oncol. 1986 Mar; 31(3):214-7.
    View in: PubMed
    Score: 0.001
  60. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1986 Feb; 70(2):307-8.
    View in: PubMed
    Score: 0.001
  61. Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council. Cancer. 1985 Sep 15; 56(6):1311-5.
    View in: PubMed
    Score: 0.001
  62. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
    View in: PubMed
    Score: 0.000
  63. Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients. Cancer. 1985 Jun 01; 55(11):2677-87.
    View in: PubMed
    Score: 0.000
  64. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 1985 Feb; 45(2):863-71.
    View in: PubMed
    Score: 0.000
  65. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
    View in: PubMed
    Score: 0.000
  66. Phase II study of spirogermanium in advanced breast cancer. Cancer Treat Rep. 1984 Dec; 68(12):1515-6.
    View in: PubMed
    Score: 0.000
  67. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial. Cancer Treat Rep. 1984 Oct; 68(10):1303-4.
    View in: PubMed
    Score: 0.000
  68. Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol. 1984 Aug; 26(4):233-7.
    View in: PubMed
    Score: 0.000
  69. Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients. J Biol Response Mod. 1983; 2(3):251-62.
    View in: PubMed
    Score: 0.000
  70. Preoperative and follow-up procedures on patients with breast cancer. Cancer. 1980 Aug 15; 46(4 Suppl):977-9.
    View in: PubMed
    Score: 0.000
  71. Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA. 1980 Jul 18; 244(3):243-6.
    View in: PubMed
    Score: 0.000
  72. Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 01; 46(1):229-32.
    View in: PubMed
    Score: 0.000
  73. Metastatic basal cell carcinoma. J Surg Oncol. 1980; 15(2):171-80.
    View in: PubMed
    Score: 0.000
  74. Preoperative physical assessment of thyroid glands in previously irradiated patients. Am J Surg. 1979 Nov; 138(5):666-7.
    View in: PubMed
    Score: 0.000
  75. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer. 1979 Mar; 43(3):956-60.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.